T1	PROC 250 253	TAR
#1	AnnotatorNotes T1	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T2	DISO 82 103	infectados por el VIH
#2	AnnotatorNotes T2	C0458074; Human immunodeficiency virus (HIV) status; Finding
T3	PROC 108 135	tratamiento antirretroviral
#3	AnnotatorNotes T3	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T4	PROC 28 68	calidad de vida relacionada con la salud
T5	PROC 221 248	tratamiento antirretroviral
#4	AnnotatorNotes T5	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T6	PROC 311 325	diagnosticados
#5	AnnotatorNotes T6	C0011900; Diagnosis; Diagnostic Procedure
T7	PROC 351 354	TAR
#6	AnnotatorNotes T7	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T8	PROC 269 284	calidad de vida
#7	AnnotatorNotes T8	C0281588; Assessment of quality of life; Diagnostic Procedure
T9	DISO 329 346	infección por VIH
#8	AnnotatorNotes T9	C0019693; HIV Infections; Disease or Syndrome
T10	PROC 646 658	cuestionario
#9	AnnotatorNotes T10	C2960239; Assessment using health assessment questionnaire; Health Care Activity | C1882515; Questionnaire Administration; Health Care Activity
T11	PROC 391 440	Estudio observacional, transversal, multicéntrico
#10	AnnotatorNotes T11	C0010362; Cross-Sectional Studies; Research Activity + C1096776; Multicenter Study; Research Activity + C1518527; Observational Study; Research Activity
T12	PROC 1792 1807	calidad de vida
#11	AnnotatorNotes T12	C0281588; Assessment of quality of life; Diagnostic Procedure
T13	PROC 286 288	CV
#12	AnnotatorNotes T13	C0281588; Assessment of quality of life; Diagnostic Procedure
T14	PROC 671 673	CV
#13	AnnotatorNotes T14	C0281588; Assessment of quality of life; Diagnostic Procedure
T15	PROC 603 626	escala visual analógica
#14	AnnotatorNotes T15	C0042815; Visual Analog Pain Scale; Diagnostic Procedure | C2959685; Assessment using visual analog scale; Health Care Activity
T16	PROC 976 1016	evaluación realizada por el cuestionario
#15	AnnotatorNotes T16	C2960239; Assessment using health assessment questionnaire; Health Care Activity | C1882515; Questionnaire Administration; Health Care Activity
T17	PROC 1034 1037	EVA
#16	AnnotatorNotes T17	C0042815; Visual Analog Pain Scale; Diagnostic Procedure | C2959685; Assessment using visual analog scale; Health Care Activity
T18	DISO 1415 1431	efectos adversos
#17	AnnotatorNotes T18	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T19	PROC 1295 1298	TAR
#18	AnnotatorNotes T19	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T20	PROC 1598 1601	TAR
#19	AnnotatorNotes T20	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T21	CHEM 120 135	antirretroviral
#20	AnnotatorNotes T21	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T22	CHEM 233 248	antirretroviral
#21	AnnotatorNotes T22	C0599685; Anti-Retroviral Agents; Pharmacologic Substance
T23	CHEM 1455 1461	grasas
#22	AnnotatorNotes T23	C0015677; Fatty acid glycerol esters; Organic Chemical · Pharmacologic Substance
T24	PROC 1625 1628	TAR
#23	AnnotatorNotes T24	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T25	PROC 1786 1789	TAR
#24	AnnotatorNotes T25	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T26	LIVB 72 81	pacientes
#25	AnnotatorNotes T26	C0030705; Patients; Patient or Disabled Group
T27	LIVB 100 103	VIH
#26	AnnotatorNotes T27	C0019682; HIV; Virus
T29	LIVB 293 310	pacientes adultos
#27	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T30	Dose 513 542	1, 2-4 o más de 4 comprimidos
T31	Frequency 543 549	al día
T32	LIVB 679 682	HIV
#28	AnnotatorNotes T32	C0019682; HIV; Virus
T33	LIVB 696 704	paciente
#29	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	LIVB 816 825	pacientes
#30	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	Age 840 855	46,0 ± 9,2 años
T36	Frequency 874 878	/día
T37	Frequency 885 889	/día
T38	Frequency 897 901	/día
T39	LIVB 937 946	pacientes
#31	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T40	Frequency 1135 1139	/día
T41	LIVB 1158 1167	pacientes
#32	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T43	Frequency 1360 1364	/día
T44	PHYS 1436 1461	metabolismo de las grasas
#33	AnnotatorNotes T44	C0598783; Lipid Metabolism; Molecular Function
T46	LIVB 1518 1527	pacientes
#34	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 1611 1620	pacientes
#35	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	LIVB 1664 1673	pacientes
#36	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	Frequency 1687 1691	/día
T52	LIVB 343 346	VIH
#37	AnnotatorNotes T52	C0019682; HIV; Virus
T53	Form 531 542	comprimidos
#38	AnnotatorNotes T53	C0039225; Tablet Dosage Form; Biomedical or Dental Material
T28	LIVB 831 838	varones
#39	AnnotatorNotes T28	C0025266; Male population group; Population Group
T54	Dose 872 874	1c
#40	AnnotatorNotes T54	[1 pill]
T55	Dose 880 885	2-4 c
#41	AnnotatorNotes T55	[2-4 pills]
T56	Dose 892 897	> 4 c
#42	AnnotatorNotes T56	[More than 4 pills]
T57	Dose 1133 1135	1c
#43	AnnotatorNotes T57	[1 pill]
T42	Dose 1357 1360	1 c
#44	AnnotatorNotes T42	[1 pill]
T45	Dose 1684 1687	1 c
#45	AnnotatorNotes T45	[1 pill]
A1	Population_data T29 Age
T50	Neg_cue 1734 1736	no
T51	CONC 1748 1759	correlación
A2	Assertion T51 Negated
#46	AnnotatorNotes T51	C1707520; Correlation; Qualitative Concept
R1	Negation Arg1:T50 Arg2:T51	
T58	Neg_cue 1693 1695	no
T59	CONC 1696 1703	difiere
A3	Assertion T59 Negated
#47	AnnotatorNotes T59	C1705241; Delta (difference); Quantitative Concept
R2	Negation Arg1:T58 Arg2:T59	
T60	CONC 1216 1223	difiere
A4	Assertion T60 Negated
#48	AnnotatorNotes T60	C1705241; Delta (difference); Quantitative Concept
T61	Neg_cue 1213 1215	no
R3	Negation Arg1:T61 Arg2:T60	
T62	CONC 1480 1491	diferencias
A5	Assertion T62 Negated
#49	AnnotatorNotes T62	C1705241; Delta (difference); Quantitative Concept
T63	Neg_cue 1463 1465	No
R4	Negation Arg1:T63 Arg2:T62	
T64	Observation 1 11	Adherencia
#50	AnnotatorNotes T64	C2364172; Adherence To Medication Regime; Finding
T65	Observation 256 266	adherencia
#51	AnnotatorNotes T65	C2364172; Adherence To Medication Regime; Finding
T66	Observation 552 562	adherencia
#52	AnnotatorNotes T66	C2364172; Adherence To Medication Regime; Finding
T67	Observation 749 759	adherencia
#53	AnnotatorNotes T67	C2364172; Adherence To Medication Regime; Finding
T68	Observation 705 714	adherente
#54	AnnotatorNotes T68	C2364172; Adherence To Medication Regime; Finding
T69	Observation 1168 1178	adherentes
#55	AnnotatorNotes T69	C2364172; Adherence To Medication Regime; Finding
T70	Observation 1537 1547	adherencia
#56	AnnotatorNotes T70	C2364172; Adherence To Medication Regime; Finding
T71	Observation 1721 1731	adherencia
#57	AnnotatorNotes T71	C2364172; Adherence To Medication Regime; Finding
T72	Observation 1567 1577	adherencia
#58	AnnotatorNotes T72	C2364172; Adherence To Medication Regime; Finding
T73	Observation 13 25	satisfacción
#59	AnnotatorNotes T73	C3476649; Treatment satisfaction; Finding
T74	Observation 201 213	satisfacción
#60	AnnotatorNotes T74	C3476649; Treatment satisfaction; Finding
T75	Observation 632 644	satisfacción
#61	AnnotatorNotes T75	C3476649; Treatment satisfaction; Finding
T76	Observation 1279 1291	satisfacción
#62	AnnotatorNotes T76	C3476649; Treatment satisfaction; Finding
R5	Overlap Arg1:T76 Arg2:T19	
T77	Observation 1641 1653	satisfacción
#63	AnnotatorNotes T77	C3476649; Treatment satisfaction; Finding
T78	Observation 1582 1594	satisfacción
#64	AnnotatorNotes T78	C3476649; Treatment satisfaction; Finding
R6	Overlap Arg1:T78 Arg2:T20	
R7	Overlap Arg1:T72 Arg2:T20	
R8	Overlap Arg1:T72 Arg2:T24	
R9	Experiences Arg1:T47 Arg2:T24	
R10	Experiences Arg1:T47 Arg2:T20	
R11	Experiences Arg1:T47 Arg2:T78	
R12	Experiences Arg1:T47 Arg2:T72	
T79	Observation 1766 1778	satisfacción
#65	AnnotatorNotes T79	C3476649; Treatment satisfaction; Finding
R13	Overlap Arg1:T79 Arg2:T25	
R14	Experiences Arg1:T48 Arg2:T77	
R15	Experiences Arg1:T48 Arg2:T71	
R16	Overlap Arg1:T71 Arg2:T79	
T80	Observation 1498 1510	satisfacción
#66	AnnotatorNotes T80	C3476649; Treatment satisfaction; Finding
T81	Observation 1392 1404	satisfacción
#67	AnnotatorNotes T81	C3476649; Treatment satisfaction; Finding
R17	Experiences Arg1:T26 Arg2:T64	
R18	Experiences Arg1:T26 Arg2:T73	
R19	Experiences Arg1:T26 Arg2:T4	
R20	Experiences Arg1:T26 Arg2:T2	
R21	Causes Arg1:T27 Arg2:T2	
R22	Experiences Arg1:T26 Arg2:T3	
R24	Before Arg1:T3 Arg2:T4	
R25	Causes Arg1:T3 Arg2:T73	
R26	Overlap Arg1:T64 Arg2:T3	
R27	Overlap Arg1:T74 Arg2:T5	
R28	Overlap Arg1:T74 Arg2:T1	
R29	Overlap Arg1:T5 Arg2:T65	
R30	Overlap Arg1:T1 Arg2:T65	
R31	Experiences Arg1:T29 Arg2:T74	
R32	Experiences Arg1:T29 Arg2:T5	
R33	Experiences Arg1:T29 Arg2:T1	
R34	Experiences Arg1:T29 Arg2:T65	
R35	Experiences Arg1:T29 Arg2:T8	
R36	Experiences Arg1:T29 Arg2:T13	
R37	Used_for Arg1:T22 Arg2:T5	
R38	Used_for Arg1:T21 Arg2:T3	
R41	Experiences Arg1:T29 Arg2:T9	
R42	Causes Arg1:T52 Arg2:T9	
R43	Experiences Arg1:T29 Arg2:T7	
T82	CONC 364 380	carga posológica
#68	AnnotatorNotes T82	C0178602; Dosage; Quantitative Concept (?)
R47	Used_for Arg1:T82 Arg2:T7	
R48	Used_for Arg1:T82 Arg2:T5	
R49	Used_for Arg1:T82 Arg2:T1	
T83	CONC 456 483	variables sociodemográficas
T84	CONC 495 511	carga posológica
#69	AnnotatorNotes T84	C0178602; Dosage; Quantitative Concept (?)
T85	CONC 564 568	SMAQ
#70	AnnotatorNotes T85	[Simplified Medication Adherence Questionnaire]
T86	CONC 570 595	registros de dispensación
#71	AnnotatorNotes T83	C4684639; Demographic Data; Intellectual Product (?)
T87	CONC 456 465;485 493	variables clínicas
T88	CONC 646 664	cuestionario ESTAR
R50	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T68	
T89	CONC 675 682	MOS-HIV
#72	AnnotatorNotes T89	[Medical Outcomes Study HIV Health Survey] 
T90	CONC 766 770	SMAQ
R51	Has_Age Arg1:T34 Arg2:T35	
R52	Has_Age Arg1:T28 Arg2:T35	
#73	AnnotatorNotes T90	[Simplified Medication Adherence Questionnaire]
T91	CONC 1017 1021	SMAQ
#74	AnnotatorNotes T91	[Simplified Medication Adherence Questionnaire]
R53	Used_for Arg1:T91 Arg2:T16	
R54	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T69	
R55	Experiences Arg1:T41 Arg2:T17	
R56	Experiences Arg1:T41 Arg2:T16	
T92	CONC 1258 1274	carga posológica
#75	AnnotatorNotes T92	C0178602; Dosage; Quantitative Concept (?)
R57	Overlap Arg1:T18 Arg2:T44	
R58	Before Arg1:T19 Arg2:T18	
R59	Experiences Arg1:T46 Arg2:T80	
R60	Experiences Arg1:T46 Arg2:T70	
R61	Experiences Arg1:T48 Arg2:T12	
R62	Experiences Arg1:T48 Arg2:T25	
R72	Overlap Arg1:T69 Arg2:T92	
R73	Causes Arg1:T19 Arg2:T81	
A6	Experiencer T26 Patient
A7	Experiencer T29 Patient
A8	Experiencer T34 Patient
A9	Experiencer T28 Patient
A10	Experiencer T39 Patient
A11	Experiencer T41 Patient
A12	Experiencer T46 Patient
A13	Experiencer T47 Patient
A14	Experiencer T48 Patient
A15	Experiencer T33 Patient
